Brimonidine Impurity 12
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Brimonidine Impurity 12

● In Stock

Catalogue No.:VE0012899
CAS No.:N/A
Mol. Formula:C11H9N5
Mol. Weight:211.23 g/mol

Additional information on Brimonidine Impurity 12

Parent drug

Brimonidine

IUPAC Name

9, 10-dihydro-8H-imidazo[2′, 1′:2, 3]imidazo[4, 5-f]quinoxaline

Synonyms

N/A

Smiles

C12=C(N3C(NCC3)=N4)C4=CC=C1N=CC=N2

InChI

InChI=1S/C11H9N5/c1-2-8-10(9-7(1)12-3-4-13-9)16-6-5-14-11(16)15-8/h1-4H,5-6H2,(H,14,15)

Description

The compound is Brimonidine Impurity 12 a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Brimonidine. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Products quotation
Name
Url
 
This field is hidden when viewing the form
This field is hidden when viewing the form